The best + ICD trial

R. Cappato, M. G. Bongiorni, M. Brignole, A. Capucci, F. Gaita, S. Mangiameli, A. Montenero, R. Pedretti, A. Raviele, J. Salerno, S. Sermasi

Research output: Contribution to journalArticlepeer-review


The BEta-blocker STrategy plus Implantable Cardioverter Defibrillator (BEST + ICD) Trial is a multicenter prospective randomized study in which the hypothesis will be tested of whether, in high-risk post-myocardial infarction (MI) patients already treated with β-blockers, therapy guided by electrophysiologic study (EPS) will improve survival, compared to conventional therapy. Eligible patients for the study are survivors of a recent MI (>5 and

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalHerzschrittmachertherapie und Elektrophysiologie
Issue numberSUPPL. 2
Publication statusPublished - 1999


  • Defibrillator
  • Implantable cardioverter
  • Primary prevention
  • Prophylactic implantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The best + ICD trial'. Together they form a unique fingerprint.

Cite this